How Could FDA’s New Guidance Affect COVID-19 Vaccination Coverage in the U.S.?
Quick Take
Taken together, the new guidance on clinical trial requirements, the more restricted approval of the Novavax vaccine, and anticipated changes to CDC recommendations add up to fewer Americans eligible for COVID-19 vaccines and more limited access to these vaccines compared to previous years…such a shift would place the U.S. more in line with Australia, Canada, and countries in Europe.